# Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

> **NCT00887679** · PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 30 (actual)

## Conditions studied

- Anxiety Disorders
- HIV Infections

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT00887679
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-09
- **Final completion:** 2010-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887679, "Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00887679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*